Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease systemic scleroderma
Comorbidity C0034069|pulmonary fibrosis
Sentences 12
PubMedID- 21239758 Objective: to clarify the clinical significance of concentrations of serum clara cell 16-kda protein (cc16; previously denoted cc10) in the diagnosis and monitoring of pulmonary fibrosis (pf) in patients with systemic sclerosis (ssc); and to compare cc16 levels with levels of the current most reliable serum markers for pf, such as krebs von den lungen-6 (kl-6) antigen and surfactant protein-d (sp-d).
PubMedID- 22096366 In wound healing, they differentiate into myofibroblasts, yet remain able to present antigen to lymphocytes.31 in animal models of lung fibrosis, circulating fibrocytes are recruited to injured lungs as an integral component of the pathogenesis of pulmonary fibrosis.32 in patients with systemic sclerosis, there are more fibrocytes in the circulation, expressing higher levels of il-10 upon proinflammatory stimulation compared with healthy individuals.33 the concept of fibrocytes being involved in ild is appealing because these cells are derived from an inexhaustible source, the bone marrow, and thus can replenish fibrotic effector cells in the tissue.
PubMedID- 21637368 Percentage volumes of calgranulin b proved significantly higher in bal of ipf patients than sarcoidosis patients or patients with pulmonary fibrosis associated with systemic sclerosis or controls (figure 1) [45].
PubMedID- 20156945 Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
PubMedID- 21107283 pulmonary fibrosis in systemic sclerosis: association with myocardial fibrosis.
PubMedID- 26444860 In a study using lung tissues from systemic sclerosis patients with pulmonary fibrosis and pulmonary hypertension, hsu et al.
PubMedID- 23949623 Utility of an open-source dicom viewer software (osirix) to assess pulmonary fibrosis in systemic sclerosis: preliminary results.
PubMedID- 19844733 Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase a, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
PubMedID- 25505696 Ger disease (gerd) has been associated with ipf and with pulmonary fibrosis in patients with systemic sclerosis (scleroderma), and ger with aspiration may play a role in triggering and/or driving lung inflammation and fibrosis in ipf and scleroderma, and it has been linked to acute exacerbations in patients with ipf [15, 16].
PubMedID- 25849157 pulmonary fibrosis, idiopathic, in patients with systemic sclerosis or post-radiation or chemotherapy, is a major cause of death and its treatment is considered a major unmet need [2].
PubMedID- 26099251 Ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography.
PubMedID- 20425529 Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease.

Page: 1